[1] [1] ZAJ.C A E, KOPE. S, SZOSTAKOWSKI B, et al. Chondrosar-coma-from molecular pathology to novel therapies［J］ . Cancers (Basel), 2021, 13(10): 2390.

[2] [2] ROCK A, ALI S, CHOW W A. Systemic therapy for chondrosar-coma［J］ . Current Treatment Options in Oncology, 2022, 23(2): 199-209.

[3] [3] PENNINGTON Z, EHRESMAN J, PITTMAN P D, et al. Chon-drosarcoma of the spine: a narrative review［J］ . Spine Journal, 2021, 21(12): 2078-2096.

[5] [5] HOSSEINI A, RAZAVI B M, BANACH M, et al. Quercetin and metabolic syndrome: a review［J］ . Phytotherapy Research, 2021, 35(10): 5352-5364.

[7] [7] VINAYAK M, MAURYA A K. Quercetin loaded nanoparticles in targeting cancer: recent development［J］ . Anti-cancer Agents in Medicinal Chemistry, 2019, 19(13): 1560-1576.

[8] [8] SHAFABAKHSH R, ASEMI Z. Quercetin: a natural compound for ovarian cancer treatment［J］ . Journal of Ovarian Research, 2019, 12(1): 55.

[9] [9] LU X, YANG F, CHEN D, et al. Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways［J］ . International Journal of Biological Sci-ences, 2020, 16(7): 1121-1134.

[10] [10] MALEKI DANA P, SADOUGHI F, ASEMI Z, et al. Anti-cancer properties of quercetin in osteosarcoma［J］ . Cancer Cell Interna-tional, 2021, 21(1): 349.

[13] [13] HE J, ZHANG W, DI T, et al. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody［J］ . Biomedicine & Pharmacotherapy, 2020, 131: 110541.

[14] [14] WHELAN J S, DAVIS L E. Osteosarcoma, chondrosarcoma, and chordoma［J］ . Journal of Clinical Oncology, 2018, 36(2): 188-193.

[16] [16] REYES-FARIAS M, CARRASCO-POZO C. The anti-cancer ef-fect of quercetin: molecular implications in cancer metabolism［J］ . International Journal of Molecular Sciences, 2019, 20(13): 3177.

[17] [17] WARD A B, MIR H, KAPUR N, et al. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic path-ways［J］ . World Journal of Surgical Oncology, 2018, 16(1): 108.

[18] [18] KASIRI N, RAHMATI M, AHMADI L, et al. Therapeutic poten-tial of quercetin on human breast cancer in different dimensions［J］ . Inflammopharmacology, 2020, 28(1): 39-62.

[19] [19] DAVOODVANDI A, SHABANI VARKANI M, et al. Quercetin as an anticancer agent: focus on esophageal cancer［J］ . Journal of Food Biochemistry, 2020, 44(9): e13374.

[20] [20] LAN H, HONG W, FAN P, et al. Quercetin inhibits cell migration and invasion in human osteosarcoma cells［J］ . Cellular Physiol-ogy and Biochemistry, 2017, 43(2): 553-567.

[24] [24] LU W, KANG Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis［J］ . Developmental Cell, 2019, 49(3): 361-374.

[25] [25] PASTUSHENKO I, BLANPAIN C. EMT transition states during tumor progression and metastasis［J］ . Trends in Cell Biology, 2019, 29(3): 212-226.

[27] [27] WU L, LI J, LIU T, et al. Quercetin shows anti-tumor effect in he-patocellular carcinoma LM3 cells by abrogating JAK2/STAT3 sig-naling pathway［J］ . Cancer Medicine, 2019, 8(10): 4806-4820.